⌕
Aurinia Pharmaceuticals · AUPH · Nasdaq
Tenet 82 · Strong
Compare
$15.40−0.52%At closeTenet 82 · Strong
$15.40−0.08 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Aurinia Pharmaceuticals (AUPH) Institutional Ownership

13F filers reported holding 8.8% of Aurinia Pharmaceuticals (AUPH) shares as of Sep 30, 2026, across 129 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
8.8%
Sep 30, 2026
13F filers
129
quarter ended Sep 30, 2026
13F value
$190.7M
11.8M shares
Quarter's fund flow
Mild accumulation
16 new · 14 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (16 new · 51 increased · 28 reduced · 14 closed · 20 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 129 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 13, 2026Robertson Stephen P.Chief Legal OfficerDisposed · Open-market sale11,867$15.97↗
Sep 10, 2026Robertson Stephen P.Chief Legal OfficerDisposed · Open-market sale11,939$15.95↗
Aug 21, 2026Robertson Stephen P.Chief Legal OfficerDisposed · Open-market sale20,975$16.97↗
Jun 4, 2026Goetz KathleendirectorAcquired · Grant / award23,931Director Stock Option (right to buy)—↗
Jun 4, 2026Bailey Jeffrey AllendirectorAcquired · Grant / award23,931Director Stock Option (right to buy)—↗
Jun 4, 2026Johnson Craig AdirectorAcquired · Grant / award23,931Director Stock Option (right to buy)—↗
Jun 4, 2026Nova Tina SusandirectorAcquired · Grant / award23,931Director Stock Option (right to buy)—↗
Jun 2, 2026TANG KEVIN CChief Executive OfficerAcquired · Open-market buy206,005Common Shares$15.28↗
Jun 2, 2026TANG KEVIN CChief Executive OfficerAcquired · Other10,000Short Put Options (potential obligation to buy)$1.65↗
Jun 1, 2026TANG KEVIN CChief Executive OfficerAcquired · Open-market buy343,521Common Shares$15.28↗
Jun 1, 2026TANG KEVIN CChief Executive OfficerAcquired · Open-market buy99Common Shares$15.34↗
May 29, 2026TANG KEVIN CChief Executive OfficerAcquired · Open-market buy2,299Common Shares$15.35↗
May 29, 2026TANG KEVIN CChief Executive OfficerAcquired · Open-market buy262,682Common Shares$15.31↗
May 18, 2026Cole RyanChief Operating OfficerAcquired · Grant / award116,144—↗
May 18, 2026Cole RyanChief Operating OfficerAcquired · Grant / award70,230Employee Stock Option (right to buy)—↗
May 18, 2026Robertson Stephen P.Chief Legal OfficerAcquired · Grant / award115,541—↗
May 18, 2026Hearne Michael SChief Financial OfficerAcquired · Grant / award116,144—↗
May 18, 2026Hearne Michael SChief Financial OfficerAcquired · Grant / award70,230Employee Stock Option (right to buy)—↗
Mar 6, 2026Keenan GregSVP, Chief Medical OfficerDisposed · Tax withholding8,069$14.32↗
Mar 3, 2026TANG KEVIN CdirectorAcquired · Open-market buy184,208Common Shares$14.22↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Aurinia Pharmaceuticals do institutions hold?

13F filers reported holding 8.8% of Aurinia Pharmaceuticals' shares as of Sep 30, 2026, across 129 filers.

How many 13F filers hold Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals was held by 129 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.